Clinical Trial Update: Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chiauranib in combination with chemotherapy for ovarian cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Chiauranib (Chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED